PMID- 29999549 OWN - NLM STAT- MEDLINE DCOM- 20190212 LR - 20190215 IS - 1464-5491 (Electronic) IS - 0742-3071 (Linking) VI - 35 IP - 11 DP - 2018 Nov TI - Cardiovascular autonomic neuropathy and bone metabolism in Type 1 diabetes. PG - 1596-1604 LID - 10.1111/dme.13777 [doi] AB - AIM: To investigate the association between cardiovascular autonomic neuropathy and bone metabolism in people with Type 1 diabetes. METHODS: We assessed cardiovascular autonomic neuropathy in 329 people with Type 1 diabetes according to heart rate response to deep breathing, to standing and to the Valsalva manoeuvre, and 2-min resting heart rate. More than one pathological non-resting test was defined as cardiovascular autonomic neuropathy. Bone mineral density of the femoral neck (BMDfn) was assessed by dual energy X-ray absorptiometry. Serum parathyroid hormone levels and other bone markers were measured. RESULTS: The mean (sd) age of the participants was 55.6 (9.4) years, 52% were men, and the mean (sd) diabetes duration was 40 (8.9) years, HbA(1c) 62 (9) mmol/mol and estimated GFR 78 (26) ml/min/1.73m(2) . In all, 36% had cardiovascular autonomic neuropathy. Participants with cardiovascular autonomic neuropathy had 4.2% (95% CI -8.0 to -0.2; P=0.038) lower BMDfn and 33.6% (95% CI 14.3 to 53.8; P=0.0002) higher parathyroid hormone levels compared with participants without cardiovascular autonomic neuropathy in adjusted models. Higher resting heart rate remained associated with higher parathyroid hormone level and lower BMDfn after additional adjustment for eGFR (P<0.0001 and P = 0.042, respectively). CONCLUSIONS: The presence of cardiovascular autonomic neuropathy was associated with reduced BMDfn and increased levels of parathyroid hormone. Kidney function may either confound or mediate these findings. Cardiovascular autonomic neuropathy could be associated with increased risk of osteoporosis in Type 1 diabetes. Whether cardiovascular autonomic neuropathy directly affects bone metabolism detrimentally or if this association is mediated via decreased kidney function should be investigated further. CI - (c) 2018 Diabetes UK. FAU - Hansen, C S AU - Hansen CS AUID- ORCID: 0000-0002-5782-3476 AD - Steno Diabetes Centre Copenhagen, Gentofte, Denmark. FAU - Theilade, S AU - Theilade S AD - Steno Diabetes Centre Copenhagen, Gentofte, Denmark. FAU - Lajer, M AU - Lajer M AD - Steno Diabetes Centre Copenhagen, Gentofte, Denmark. FAU - Hansen, T W AU - Hansen TW AD - Steno Diabetes Centre Copenhagen, Gentofte, Denmark. FAU - Rossing, P AU - Rossing P AD - Steno Diabetes Centre Copenhagen, Gentofte, Denmark. AD - Department of Clinical Medicine, Faculty of Health, Aarhus, Denmark. AD - Department of Public Health, Aarhus University, Aarhus, Denmark. AD - Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark. LA - eng GR - HEALTH-F2-2009-241544/European Community's Seventh Framework programme/International PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20180820 PL - England TA - Diabet Med JT - Diabetic medicine : a journal of the British Diabetic Association JID - 8500858 SB - IM MH - Adult MH - Aged MH - Aged, 80 and over MH - Autonomic Nervous System Diseases/complications/*epidemiology MH - Bone Density MH - Bone and Bones/*metabolism MH - Cardiovascular Diseases/complications/*epidemiology MH - Case-Control Studies MH - Cross-Sectional Studies MH - Diabetes Mellitus, Type 1/*complications/*epidemiology MH - Diabetic Angiopathies/complications/*epidemiology/metabolism MH - Diabetic Neuropathies/epidemiology MH - Female MH - Humans MH - Male MH - Middle Aged MH - Osteoporosis/*epidemiology/etiology/metabolism MH - Risk Factors MH - Young Adult EDAT- 2018/07/13 06:00 MHDA- 2019/02/13 06:00 CRDT- 2018/07/13 06:00 PHST- 2018/07/10 00:00 [accepted] PHST- 2018/07/13 06:00 [pubmed] PHST- 2019/02/13 06:00 [medline] PHST- 2018/07/13 06:00 [entrez] AID - 10.1111/dme.13777 [doi] PST - ppublish SO - Diabet Med. 2018 Nov;35(11):1596-1604. doi: 10.1111/dme.13777. Epub 2018 Aug 20.